SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 238 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $322 | -98.8% | 2,488 | +1144.0% | 0.01% | +600.0% |
| Q4 2019 | $26,000 | +73.3% | 200 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $15,000 | -85.0% | 200 | -69.7% | 0.00% | -87.5% |
| Q2 2019 | $100,000 | +66.7% | 660 | +32.0% | 0.01% | +60.0% |
| Q1 2019 | $60,000 | +172.7% | 500 | +150.0% | 0.01% | +150.0% |
| Q4 2018 | $22,000 | -4.3% | 200 | -60.0% | 0.00% | -33.3% |
| Q3 2017 | $23,000 | +53.3% | 500 | -54.5% | 0.00% | 0.0% |
| Q1 2015 | $15,000 | -6.2% | 1,100 | 0.0% | 0.00% | -25.0% |
| Q4 2014 | $16,000 | +700.0% | 1,100 | +1000.0% | 0.00% | – |
| Q3 2014 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |